OUR TECHnology

Our platform is uniquely able to target multiple misfolded protein aggregates implicated in serious diseases

AN URGENT NEED

Learn about our approach to meet the dire need for new treatments for neurodegenerative diseases

LATEST NEWS

Proclara Biosciences Announces $47 Million in New Investment to Support the Development of Product Candidates in Alzheimer’s, Parkinson’s and Other Diseases